Sialorrhea or excessive drooling is a common symptom associated with various neurological disorders like Parkinson's disease, amyotrophic lateral sclerosis (ALS) and cerebral palsy among others. It refers to excessive production or reduced clearance of saliva from the mouth. Untreated sialorrhea can lead to skin irritation, infections and social discomfort. Sialorrhea treatment aims to reduce excess saliva production or enhance clearance. Some of the treatment options include botulinum toxin injections, anticholinergic drugs and radiation therapy. With rising prevalence of neurological conditions worldwide, the need for effective sialorrhea treatment options is increasing.
The sialorrhea treatment market is estimated to be valued at USD 771 Mn in 2024 and is expected to reach USD 1,110 Mn by 2031, growing at a compound annual growth rate (CAGR) of 5.30% from 2024 to 2031.
The Global Sialorrhea Treatment Market is facing several geopolitical headwinds that are impacting its growth prospects across regions. The ongoing geo-political tensions and economic uncertainties arising due to the COVID-19 pandemic and Russia-Ukraine conflict have disrupted supply chains and manufacturing hubs worldwide. This has hampered the consistent supply of sialorrhea drugs and devices, especially in the European region which has direct economic dependencies on Russia and Ukraine.
Get More Insights On- Global Sialorrhea Treatment Market
Get This Report in Japanese Language: 世界の流汗症治療市場
Get This Report in Japanese Language: 글로벌 타액치료 시장
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Italiano
Russian
Romaian